Evidence map›Paper›PMID 25367910›Full record

ArticleAntimicrobial agents and chemotherapy2015

Optimization of a nucleic acid-based reporter system to detect Mycobacterium tuberculosis antibiotic sensitivity.

Matthew C Mulvey, Margaret Lemmon, Stephanie Rotter, Jonathan Lees, Leo Einck, Carol A Nacy

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew C MulveySequella, Inc., Rockville, Maryland, USA BeneVir Biopharm, Inc., Rockville, Maryland, USA matthewmulvey@sequella.com.
Margaret LemmonSequella, Inc., Rockville, Maryland, USA.
Stephanie RotterSequella, Inc., Rockville, Maryland, USA.
Jonathan LeesSequella, Inc., Rockville, Maryland, USA.
Leo EinckSequella, Inc., Rockville, Maryland, USA.
Carol A NacySequella, Inc., Rockville, Maryland, USA.
Sequella (United States) · USSigmovir Biosystems (United States) · US

Funding

A Kit for Rapid AST of Mycobacterium tuberculosis from Clinical SamplesR21AI096248 · NIAID · SEQUELLA, INC. · PI MULVEY, MATTHEW CHARLES · 2012 to 2013
$440k
NIAID NIH HHS 1R21AI096248-01A1NIAID NIH HHS R21 AI096248
6 · The paper itself

Abstract

We previously reported the development of a prototype antibiotic sensitivity assay to detect drug-resistant Mycobacterium tuberculosis using infection by mycobacteriophage to create a novel nucleic acid transcript, a surrogate marker of mycobacterial viability, detected by reverse transcriptase PCR (M. C. Mulvey et al., mBio 3: e00312-11, 2012). This assay detects antibiotic resistance to all drugs, even drugs for which the resistance mechanism is unknown or complex: it is a phenotypic readout using nucleic acid detection. In this report, we describe development and characteristics of an optimized reporter system that directed expression of the RNA cyclase ribozyme, which generated circular RNA through an intramolecular splicing reaction and led to accumulation of a new nucleic acid sequence in phage-infected bacteria. These modifications simplified the assay, increased the limit of detection from 10(4) to <10(2) M. tuberculosis cells, and correctly identified the susceptibility profile of M. tuberculosis strains exposed for 16 h to either first-line or second-line antitubercular drugs. In addition to phenotypic drug resistance or susceptibility, the assay reported streptomycin MICs and clearly detected 10% drug-resistant cells in an otherwise drug-susceptible population.

Indexed as

Antitubercular AgentsDNA-Directed RNA PolymerasesDrug Resistance, Multiple, BacterialGenes, ReporterMicrobial Sensitivity TestsMycobacteriophagesMycobacterium tuberculosisRNARNA, CircularTuberculosisAntitubercular AgentsDNA-Directed RNA PolymerasesRNARNA, CircularRNA polymerase SP6

Identifiers

PMID25367910
PMCPMC4291379
OpenAlexW2094943648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.